Cypress Capital Management LLC Astrazeneca PLC Transaction History

Cypress Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$53.02 - $135.75 $55,671 - $142,537	-1,050 Reduced 1.57%	65,943 $3.62 Million
Q2 2022 Aug 10, 2022	SELL	$59.26 - $71.14 $5,926 - $7,114	-100 Reduced 0.15%	66,993 $4.43 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $25,074 - $30,204	450 Added 0.68%	67,093 $4.45 Million
Q4 2021 Feb 22, 2022	BUY	$54.02 - $63.83 $3.02 Million - $3.57 Million	55,966 Added 524.17%	66,643 $3.88 Million
Q2 2021 Aug 12, 2021	BUY	$48.42 - $60.18 $229,995 - $285,855	4,750 Added 80.14%	10,677 $640,000
Q1 2021 May 12, 2021	BUY	$47.16 - $54.44 $279,517 - $322,665	5,927 New	5,927 $295,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Cypress Capital Management LLC with notifications on news.